On February 19, 2014, Squire Sanders associate Django H. Andrews lead a BayBio Lunch & Learn session regarding the patent eligibility of Biomarker innovation in the US and abroad. The session focused on patent eligibility of Biomarkers in the US after the Prometheus and Myriad Supreme Court decisions, as well as patent eligibility in Europe and Japan.

More information regarding the presentation is available on Squire Patton Boggs’ website  and from BayBio.